The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility

Oncogene

Volumn 31, Issue 5, 2012, Pages 653-663

  Benes, C H ^a   Poulogiannis, G ^a,b   Cantley, L C ^a,b   Soltoff, S P ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

adhesion; mass spectrometry; metastasis; motility; signaling; SRC

Indexed keywords

CUB DOMAIN CONTAINING PROTEIN 1; FOCAL ADHESION KINASE; MEMBRANE PROTEIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL MOTILITY; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CELL ADHESION; CELL ADHESION MOLECULES; CELL COMMUNICATION; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; ENZYME ACTIVATION; FOCAL ADHESION KINASE 1; HCT116 CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LUNG NEOPLASMS; MUTATION; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE C; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TYROSINE;

EID: 84856545280     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.262     Document Type: Article

References (52)

1. Aligayer H, Boyd DD, Heiss MM, Abdalla EK, Curley SA, Gallick GE. (2002). Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis. Cancer 94: 344-351. (Pubitemid 34081362)
2. Alvares SM, Dunn CA, Brown TA, Wayner EE, Carter WG. (2008). The role of membrane microdomains in transmembrane signaling through the epithelial glycoprotein Gp140/CDCP1. Biochim Biophys Acta 1780: 486-496.
3. Awakura Y, Nakamura E, Takahashi T, Kotani H, Mikami Y, Kadowaki T et al. (2008). Microarray-based identification of CUBdomain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma. J Cancer Res Clin Oncol 134: 1363-1369.
4. Benes CH, Wu N, Elia AE, Dharia T, Cantley LC, Soltoff SP. (2005). The C2 domain of PKCdelta is a phosphotyrosine binding domain. Cell 121: 271-280.
5. Bhatt AS, Erdjument-Bromage H, Tempst P, Craik CS, Moasser MM. (2005). Adhesion signaling by a novel mitotic substrate of src kinases. Oncogene 24: 5333-5343. (Pubitemid 43080103)
6. Bolen JB, Veillette A, Schwartz AM, DeSeau V, Rosen N. (1987). Activation of pp60c-src protein kinase activity in human colon carcinoma. Proc Natl Acad Sci USA 84: 2251-2255. (Pubitemid 17075849)
7. Bromann PA, Korkaya H, Courtneidge SA. (2004). The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 23: 7957-7968. (Pubitemid 39468854)
8. Brunton VG, Avizienyte E, Fincham VJ, Serrels B, Metcalf III CA, Sawyer TK et al. (2005). Identification of Src-specific phosphorylation site on focal adhesion kinase: dissection of the role of Src SH2 and catalytic functions and their consequences for tumor cell behavior. Cancer Res 65: 1335-1342. (Pubitemid 40270160)
9. Brunton VG, Frame MC. (2008). Src and focal adhesion kinase as therapeutic targets in cancer. Curr Opin Pharmacol 8: 427-432.
10. Buhring HJ, Kuci S, Conze T, Rathke G, Bartolovic K, Grunebach F et al. (2004). CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin. Stem Cells 22: 334-343. (Pubitemid 38736617)
11. Cartwright CA, Kamps MP, Meisler AI, Pipas JM, Eckhart W. (1989). pp60c-src activation in human colon carcinoma. J Clin Invest 83: 2025-2033. (Pubitemid 19148875)
12. Chan KT, Cortesio CL, Huttenlocher A. (2009). FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion. J Cell Biol 185: 357-370.
13. Cooper JA, Qian H. (2008). A mechanism for SRC kinase-dependent signaling by noncatalytic receptors. Biochemistry 47: 5681-5688. (Pubitemid 351747046)
14. Courtneidge SA. (2002). Role of Src in signal transduction pathways. The Jubilee Lecture. Biochem Soc Trans 30: 11-17.
15. Deryugina EI, Conn EM, Wortmann A, Partridge JJ, Kupriyanova TA, Ardi VC et al. (2009). Functional role of cell surface CUB domain-containing protein 1 in tumor cell dissemination. Mol Cancer Res 7: 1197-1211.
16. Frame MC. (2002). Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta 1602: 114-130. (Pubitemid 34521791)
17. Frame MC. (2004). Newest findings on the oldest oncogene; how activated src does it. J Cell Sci 117: 989-998. (Pubitemid 38456081)
18. He Y, Wortmann A, Burke LJ, Reid JC, Adams MN, Abdul-Jabbar I et al. (2010). Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdelta. J Biol Chem 285: 26162-26173.
19. Hooper JD, Zijlstra A, Aimes RT, Liang H, Claassen GF, Tarin D et al. (2003). Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen. Oncogene 22: 1783-1794. (Pubitemid 36513138)
20. Huveneers S, Danen EH. (2009). Adhesion signaling-crosstalk between integrins, Src and Rho. J Cell Sci 122: 1059-1069.
21. Ikeda J, Oda T, Inoue M, Uekita T, Sakai R, OkumuraMet al. (2009). Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung. Cancer Sci 100: 429-433.
22. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N et al. (1995). Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377: 539-544.
23. Klinghoffer RA, Sachsenmaier C, Cooper JA, Soriano P. (1999). Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J 18: 2459-2471. (Pubitemid 29213279)
24. Leroy C, Fialin C, Sirvent A, Simon V, Urbach S, Poncet J et al. (2009). Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cells. Cancer Res 69: 2279-2286.
25. Liu H, Ong SE, Badu-Nkansah K, Schindler J, White FM, Hynes RO. (2011). CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis. Proc Natl Acad Sci USA 108: 1379-1384.
26. Lu Z, Jiang G, Blume-Jensen P, Hunter T. (2001). Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol 21: 4016-4031. (Pubitemid 32476463)
27. Manes S, Mira E, Gomez-Mouton C, Zhao ZJ, Lacalle RA, Martinez AC. (1999). Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility. Mol Cell Biol 19: 3125-3135. (Pubitemid 29144557)
28. McGlade J, Cheng A, Pelicci G, Pelicci PG, Pawson T. (1992). Shc proteins are phosphorylated and regulated by the v-Src and v-Fps protein-tyrosine kinases. Proc Natl Acad Sci USA 89: 8869-8873.
29. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC. (2005). The role of focal-adhesion kinase in cancer-a new therapeutic opportunity. Nat Rev Cancer 5: 505-515. (Pubitemid 40942827)
30. Mitra SK, Hanson DA, Schlaepfer DD. (2005). Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6: 56-68. (Pubitemid 40064899)
31. Mitra SK, Schlaepfer DD. (2006). Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18: 516-523. (Pubitemid 44332916)
32. Miyazawa Y, Uekita T, Hiraoka N, Fujii S, Kosuge T, Kanai Y et al. (2010). CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation. Cancer Res 70: 5136-5146.
33. Perry SE, Robinson P, Melcher A, Quirke P, Buhring HJ, Cook GP et al. (2007). Expression of the CUB domain containing protein 1 (CDCP1) gene in colorectal tumour cells. FEBS Lett 581: 1137-1142. (Pubitemid 46385936)
34. Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H et al. (2007). Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131: 1190-1203. (Pubitemid 350235027)
35. Scherl-Mostageer M, Sommergruber W, Abseher R, Hauptmann R, Ambros P, Schweifer N. (2001). Identification of a novel gene, CDCP1, overexpressed in human colorectal cancer. Oncogene 20: 4402-4408. (Pubitemid 32726882)
36. Serrels A, Macpherson IR, Evans TR, Lee FY, Clark EA, Sansom OJ et al. (2006). Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib. Mol Cancer Ther 5: 3014-3022. (Pubitemid 46092042)
37. Serrels B, Serrels A, Brunton VG, Holt M, McLean GW, Gray CH et al. (2007). Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex. Nat Cell Biol 9: 1046-1056. (Pubitemid 47338144)
38. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH et al. (2000). FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2: 249-256.
39. Sieg DJ, Hauck CR, Schlaepfer DD. (1999). Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci 112(Pt 16): 2677-2691. (Pubitemid 29429791)
40. Smyth GK. (2004). Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
41. Spassov DS, Baehner FL, Wong CH, McDonough S, Moasser MM. (2009). The transmembrane src substrate Trask is an epithelial protein that signals during anchorage deprivation. Am J Pathol 174: 1756-1765.
42. Spassov DS, Wong CH, Sergina N, Ahuja D, Fried M, Sheppard D et al. (2011). Phosphorylation of Trask by Src kinases inhibits integrin clustering and functions in exclusion with focal adhesion signaling. Mol Cell Biol 31: 766-782.
43. Talamonti MS, Roh MS, Curley SA, Gallick GE. (1993). Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. J Clin Invest 91: 53-60. (Pubitemid 23037252)
44. Tilghman RW, Slack-Davis JK, Sergina N, Martin KH, Iwanicki M, Hershey ED et al. (2005). Focal adhesion kinase is required for the spatial organization of the leading edge in migrating cells. J Cell Sci 118: 2613-2623. (Pubitemid 40932887)
45. Uekita T, Jia L, Narisawa-Saito M, Yokota J, Kiyono T, Sakai R. (2007). CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.Mol Cell Biol 27: 7649-7660. (Pubitemid 350033670)
46. Uekita T, Tanaka M, Takigahira M, Miyazawa Y, Nakanishi Y, Kanai Y et al. (2008). CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma. Am J Pathol 172: 1729-1739. (Pubitemid 351793363)
47. Vitale S, Avizienyte E, Brunton VG, Frame MC. (2008). Focal adhesion kinase is not required for Src-induced formation of invadopodia in KM12C colon cancer cells and can interfere with their assembly. Eur J Cell Biol 87: 569-579.
48. Vultur A, Buettner R, Kowolik C, Liang W, Smith D, Boschelli F et al. (2008). SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells. Mol Cancer Ther 7: 1185-1194.
49. Wortmann A, He Y, Deryugina EI, Quigley JP, Hooper JD. (2009). The cell surface glycoprotein CDCP1 in cancer-insights, opportunities, and challenges. IUBMB Life 61: 723-730.
50. Yu DH, Qu CK, Henegariu O, Lu X, Feng GS. (1998). Proteintyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion. J Biol Chem 273: 21125-21131. (Pubitemid 28385400)
51. Zhang SQ, Yang W, Kontaridis MI, Bivona TG, Wen G, Araki T et al. (2004). Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol Cell 13: 341-355. (Pubitemid 38229807)
52. Zheng Y, Xia Y, Hawke D, Halle M, Tremblay ML, Gao X et al. (2009). FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST. Mol Cell 35: 11-25.